Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Calabresi

Showing results (21-30 of 469) with videos related to

Pageof 47
Sort By:
Biotechniques|May 23, 2007
Agar-gelatin for embedding tissues prior to paraffin processingMelina V Jones, Peter A Calabresi
Neurology|February 27, 2014
Author responseElias S Sotirchos, Peter A Calabresi
Journal of Neuroimmunology|March 15, 2005
2004 Pathogenesis of rare neuroimmunologic disorders, Hyatt Regency Inner Harbor, Baltimore, MD, August 19th 2004-August 20th 2004Douglas A Kerr, Peter A Calabresi
CNS Drugs|December 29, 2011
PEGylation of interferon-β-1a: a promising strategy in multiple sclerosisBernd C Kieseier, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2022
Generic MS medications: Reducing costs without compromising safetyEmily M Schorr, Peter A Calabresi
Annals of Indian Academy of Neurology|February 26, 2010
Promising treatments of tomorrow for multiple sclerosisDaniel M Harrison, Peter A Calabresi
Neurology|March 9, 2018
Central vein sign in multiple sclerosis: Ready for front and center?Aaron E Miller, Peter A Calabresi
Seminars in Neurology|February 8, 2008
Future research directions in multiple sclerosis therapiesBenjamin M Greenberg, Peter A Calabresi
Journal of Neuroimmunology|January 1, 2017
Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosisEliza Gordon-Lipkin, Peter A Calabresi
Neurology|March 26, 2008
The diagnosis of MS: white spots and red flagsJohn N Ratchford, Peter A Calabresi
Pageof 47

Showing results (21-30 of 469) with videos related to

Sort By:
Pageof 47
Biotechniques|May 23, 2007
Agar-gelatin for embedding tissues prior to paraffin processingMelina V Jones, Peter A Calabresi
Neurology|February 27, 2014
Author responseElias S Sotirchos, Peter A Calabresi
Journal of Neuroimmunology|March 15, 2005
2004 Pathogenesis of rare neuroimmunologic disorders, Hyatt Regency Inner Harbor, Baltimore, MD, August 19th 2004-August 20th 2004Douglas A Kerr, Peter A Calabresi
CNS Drugs|December 29, 2011
PEGylation of interferon-β-1a: a promising strategy in multiple sclerosisBernd C Kieseier, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2022
Generic MS medications: Reducing costs without compromising safetyEmily M Schorr, Peter A Calabresi
Annals of Indian Academy of Neurology|February 26, 2010
Promising treatments of tomorrow for multiple sclerosisDaniel M Harrison, Peter A Calabresi
Neurology|March 9, 2018
Central vein sign in multiple sclerosis: Ready for front and center?Aaron E Miller, Peter A Calabresi
Seminars in Neurology|February 8, 2008
Future research directions in multiple sclerosis therapiesBenjamin M Greenberg, Peter A Calabresi
Journal of Neuroimmunology|January 1, 2017
Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosisEliza Gordon-Lipkin, Peter A Calabresi
Neurology|March 26, 2008
The diagnosis of MS: white spots and red flagsJohn N Ratchford, Peter A Calabresi
Pageof 47